Zealand Pharma A/S revenue for the last year amounted to 50.74 M USD, the most of which — 50.74 M USD — came from its highest performing source at the moment, Peptide-based Medicines, the year earlier bringing 14.92 M USD. The greatest contribution to the revenue figure was made by Germany — last year it brought Zealand Pharma A/S 43.59 B USD.